Roosevelt Investment Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $287K | Sell |
1,275
-28
| -2% | -$6.79K | 0.02% | 229 |
|
|
2022
Q2 | $317K | Buy |
1,303
+23
| +2% | +$5.64K | 0.02% | 210 |
|
|
2022
Q1 | $310K | Buy |
1,280
+296
| +30% | +$68K | 0.02% | 235 |
|
|
2021
Q4 | $221K | Buy |
+984
| New | +$208K | 0.01% | 260 |
|
|
2021
Q3 | – | Sell |
-940
| Closed | -$229K | – | 248 |
|
|
2021
Q2 | $229K | Sell |
940
-42
| -4% | -$10.3K | 0.01% | 231 |
|
|
2021
Q1 | $244K | Buy |
+982
| New | +$234K | 0.02% | 222 |
|
|
2020
Q3 | – | Sell |
-866
| Closed | -$204K | – | 215 |
|
|
2020
Q2 | $204K | Sell |
866
-536
| -38% | -$122K | 0.02% | 156 |
|
|
2020
Q1 | $284K | Sell |
1,402
-66
| -4% | -$14.4K | 0.03% | 119 |
|
|
2019
Q4 | $354K | Sell |
1,468
-80
| -5% | -$17.6K | 0.04% | 124 |
|
|
2019
Q3 | $300K | Buy |
1,548
+63
| +4% | +$12.1K | 0.03% | 129 |
|
|
2019
Q2 | $274K | Sell |
1,485
-103
| -6% | -$18.4K | 0.03% | 127 |
|
|
2019
Q1 | $302K | Sell |
1,588
-96
| -6% | -$18.3K | 0.04% | 123 |
|
|
2018
Q4 | $328K | Buy |
1,684
+111
| +7% | +$21.7K | 0.04% | 155 |
|
|
2018
Q3 | $326K | Hold |
1,573
| – | – | 0.03% | 129 |
|
|
2018
Q2 | $290K | Hold |
1,573
| – | – | 0.03% | 132 |
|
|
2018
Q1 | $268K | Sell |
1,573
-330
| -17% | -$60.6K | 0.03% | 148 |
|
|
2017
Q4 | $331K | Hold |
1,903
| – | – | 0.03% | 147 |
|
|
2017
Q3 | $355K | Hold |
1,903
| – | – | 0.03% | 152 |
|
|
2017
Q2 | $328K | Sell |
1,903
-30
| -2% | -$4.88K | 0.03% | 157 |
|
|
2017
Q1 | $317K | Buy |
1,933
+181
| +10% | +$30.1K | 0.03% | 170 |
|
|
2016
Q4 | $256K | Buy |
1,752
+70
| +4% | +$10.5K | 0.02% | 171 |
|
|
2016
Q3 | $281K | Buy |
1,682
+35
| +2% | +$5.92K | 0.02% | 157 |
|
|
2016
Q2 | $251K | Sell |
1,647
-11
| -0.7% | -$1.71K | 0.02% | 175 |
|
|
2016
Q1 | $249K | Sell |
1,658
-6
| -0.4% | -$891 | 0.02% | 155 |
|
|
2015
Q4 | $270K | Hold |
1,664
| – | – | 0.02% | 198 |
|
|
2015
Q3 | $230K | Sell |
1,664
-87
| -5% | -$13.7K | 0.01% | 206 |
|
|
2015
Q2 | $269K | Sell |
1,751
-21
| -1% | -$3.36K | 0.02% | 211 |
|
|
2015
Q1 | $283K | Sell |
1,772
-18
| -1% | -$2.83K | 0.02% | 208 |
|
|
2014
Q4 | $285K | Buy |
1,790
+20
| +1% | +$3.12K | 0.02% | 210 |
|
|
2014
Q3 | $249K | Buy |
+1,770
| New | +$231K | 0.01% | 213 |
|
|
2014
Q2 | – | Sell |
-1,646
| Closed | -$203K | – | 225 |
|
|
2014
Q1 | $203K | Buy |
+1,646
| New | +$200K | 0.01% | 215 |
|
Other funds holding AMGN
Roosevelt Investment Group's AMGN Position: Q3 2022 in Review
Roosevelt Investment Group reduced its Amgen (AMGN) stake by 2.1% in Q3 2022, selling an estimated $6.79K and leaving 1,275 shares worth $287K. The position accounts for 0.02% of the portfolio, ranked #229.
Roosevelt Investment Group first reported a position in AMGN in Q1 2014 and has held it in 31 quarters since. The position peaked at $355K in Q3 2017. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Roosevelt Investment Group held 1,275 shares of Amgen worth $287K as of Q3 2022.
- Roosevelt Investment Group sold 28 Amgen shares in Q3 2022, an estimated $6.79K.
- Amgen made up 0.02% of Roosevelt Investment Group's portfolio in Q3 2022, its #229 holding.
- Roosevelt Investment Group first reported a position in Amgen in Q1 2014 and has held it in 31 quarters since.
- Roosevelt Investment Group's Amgen position peaked at $355K in Q3 2017.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.